Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
251 studies found for:    alps
Show Display Options
Rank Status Study
1 Completed
Has Results
Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)
Conditions: ALPS;   Hypersplenism;   Lymphadenopathy
Interventions: Drug: Valproic Acid;   Procedure: CT Scan;   Procedure: Blood Sample
2 Completed Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Conditions: Pregnancy;   Respiratory Distress;   Pregnancy Outcome
Intervention: Drug: Corticosteroid
3 Recruiting Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Condition: Autoimmune Lymphproliferative Syndrome
Intervention:
4 Not yet recruiting Robot-Assisted Therapy and Motor Learning: An Active Learning Program for Stroke
Condition: Stroke
Interventions: Device: Robot-Assisted Therapy (RT);   Device: Robot & Task-Oriented Training (RT-TOT)
5 Completed Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma
Conditions: Lymphoproliferative Disorders;   Lymphoma
Intervention:
6 Completed Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphoproliferative Disorder
Intervention: Drug: Fansidar (pyrimethamine and sulfadoxine)
7 Completed Pyrimethamine to Treat Autoimmune Lymphoproliferative Syndrome
Conditions: Autoimmune Disease;   Lymphatic Disease;   Lymphoproliferative Disorder
Intervention: Drug: Pyrimethamine
8 Withdrawn Fluorodeoxyglucose Imaging Studies to Detect Lymphoma
Conditions: Autoimmune Lymphoproliferative Syndrome;   Lymphoma
Intervention:
9 Unknown  Asthma Learning Project
Condition: Asthma
Interventions: Other: Educational game;   Other: Educational game + motivational interview;   Other: Motivational interview
10 Completed How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)?
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Other: High sugar low starch diet;   Other: Low sugar high starch diet
11 Recruiting ANSiStim Study for Active Labor Pain
Conditions: Labor Pain;   Obstetric Pain
Intervention: Device: ANSiStim
12 Completed Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)
Conditions: Hypertension;   Coronary Atherosclerosis
Intervention: Drug: Calcium channel blockers (amlodipine, azelnidipine)
13 Not yet recruiting Asthma L-Citrulline Pilot Study
Condition: Asthma
Intervention: Drug: L-Citrulline
14 Recruiting Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis
Condition: Anemia in Chronic Kidney Disease in Non-dialysis Patients
Interventions: Drug: Roxadustat;   Drug: Placebo
15 Active, not recruiting Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Condition: Cardiac Arrest
Interventions: Drug: amiodarone;   Drug: Lidocaine;   Other: Normal saline
16 Active, not recruiting Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
Condition: Type 1 Diabetes
Interventions: Drug: Alprazolam;   Drug: Placebo
17 Completed Genetic Mapping of Atherogenic Lipoprotein Phenotypes
Conditions: Atherosclerosis;   Cardiovascular Diseases;   Heart Diseases
Intervention:
18 Recruiting Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)
Condition: Prostate Cancer Metastatic
Intervention: Drug: Osteodex
19 Terminated A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC
Condition: Prostate Cancer Metastatic
Interventions: Drug: Osteodex;   Drug: Placebo
20 Recruiting Testing Tissue Sodium Stores in CAPD Patients—Aims 1 & 2
Condition: End Stage Renal Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.